Everett Capital Advisors (UK)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-64,500
Closed -$10.9M 28
2019
Q3
$10.9M Buy
64,500
+14,500
+29% +$2.36M 1.76% 15
2019
Q2
$8.37M Buy
+50,000
New +$6.92M 1% 27

Other funds holding AGN

Everett Capital Advisors (UK)'s AGN Position: Q4 2019 in Review

Everett Capital Advisors (UK) sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 64,500 shares — an estimated $10.9M sold.

Everett Capital Advisors (UK) first reported a position in AGN in Q2 2019 and held it in 2 quarters. The position peaked at $10.9M in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Everett Capital Advisors (UK) reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Everett Capital Advisors (UK) sold 64,500 Allergan plc shares in Q4 2019, an estimated $10.9M.
  • Everett Capital Advisors (UK) first reported a position in Allergan plc in Q2 2019 and held it in 2 quarters.
  • Everett Capital Advisors (UK)'s Allergan plc position peaked at $10.9M in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Everett Capital Advisors (UK)'s 13F filing for Q4 2019, filed 15 Jan 2020.